Breaking News, Financial News

Financial Report: Quintiles

Revenues up 8% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Quintiles   4Q Revenues: $1.4 billion (+8%)   4Q Earnings: $72.9 million (+109%)   FY Revenues: $5.1 billion (+5%)   FY Earnings: $226.0 (+28%)   Comments: New business wins were $1.3 billion and $4.9 billion for the quarter and year ended December 31, 2013, respectively, representing a book-to-bill ratio of 1.29 for both the quarter and year, and contributed to an ending backlog of $9.9 billion. Product Development revenues were $775 million in the quarter, up 10%, and $2.9 billion for the year...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters